RecruitingNot ApplicableNCT06710353

The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery

The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery: A Prospective Randomized Clinical Trial


Sponsor

Seoul National University Hospital

Enrollment

190 participants

Start Date

Jan 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The study aims to evaluate whether preoperative albumin supplementation in pediatric patients with hypoalbuminemia undergoing cardiac surgery can reduce inflammatory responses and prevent acute kidney injury (AKI) following cardiopulmonary bypass.


Eligibility

Max Age: 7 Years

Inclusion Criteria2

  • Pediatric patients under 7 years of age undergoing cardiac surgery with cardiopulmonary bypass
  • Preoperative serum albumin level of 4.0 g/dL or lower

Exclusion Criteria6

  • abnormal preoperative creatinine level
  • history of dialysis
  • liver dysfunction
  • diabetes
  • history of hypersensitivity to albumin
  • coagulation disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAlbumin solution

A 20% albumin solution is administered over one hour starting from the induction of anesthesia, using the following formula: (4.0-preoperative serum albumin (g/dL))×plasma volume (kg×0.65-0.8 dL)

DRUGCrystalloid solutions

The same volume of crystalloid solution as the administered albumin is infused.


Locations(1)

Seoul National University Hospital

Seoul, Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06710353


Related Trials